Literature DB >> 31666191

Extracellular transglutaminase 2 induces myotube hypertrophy through G protein-coupled receptor 56.

Tomoya Kitakaze1, Miki Yoshikawa2, Yasuyuki Kobayashi2, Naohiro Kimura2, Naoki Goshima3, Takahiro Ishikawa4, Yoshiyuki Ogata2, Yoko Yamashita5, Hitoshi Ashida5, Naoki Harada2, Ryoichi Yamaji6.   

Abstract

Skeletal muscle secretes biologically active proteins that contribute to muscle hypertrophy in response to either exercise or dietary intake. The identification of skeletal muscle-secreted proteins that induces hypertrophy can provide critical information regarding skeletal muscle health. Dietary provitamin A, β-carotene, induces hypertrophy of the soleus muscle in mice. Here, we hypothesized that skeletal muscle produces hypertrophy-inducible secretory proteins via dietary β-carotene. Knockdown of retinoic acid receptor (RAR) γ inhibited the β-carotene-induced increase soleus muscle mass in mice. Using RNA sequencing, bioinformatic analyses, and literature searching, we predicted transglutaminase 2 (TG2) to be an all-trans retinoic acid (ATRA)-induced secretory protein in cultured C2C12 myotubes. Tg2 mRNA expression increased in ATRA- or β-carotene-stimulated myotubes and in the soleus muscle of β-carotene-treated mice. Knockdown of RARγ inhibited β-carotene-increased mRNA expression of Tg2 in the soleus muscle. ATRA increased endogenous TG2 levels in conditioned medium from myotubes. Extracellular TG2 promoted the phosphorylation of Akt, mechanistic target of rapamycin (mTOR), and ribosomal p70 S6 kinase (p70S6K), and inhibitors of mTOR, phosphatidylinositol 3-kinase, and Src (rapamycin, LY294002, and Src I1, respectively) inhibited TG2-increased phosphorylation of mTOR and p70S6K. Furthermore, extracellular TG2 promoted protein synthesis and hypertrophy in myotubes. TG2 mutant lacking transglutaminase activity exerted the same effects as wild-type TG2. Knockdown of G protein-coupled receptor 56 (GPR56) inhibited the effects of TG2 on mTOR signaling, protein synthesis, and hypertrophy. These results indicated that TG2 expression was upregulated through ATRA-mediated RARγ and that extracellular TG2 induced myotube hypertrophy by activating mTOR signaling-mediated protein synthesis through GPR56, independent of transglutaminase activity.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  G protein-coupled receptor 56; Retinoic acid receptor γ; Secretory protein; Skeletal muscle; Transglutaminase 2; mTOR

Mesh:

Substances:

Year:  2019        PMID: 31666191     DOI: 10.1016/j.bbamcr.2019.118563

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Res        ISSN: 0167-4889            Impact factor:   4.739


  6 in total

Review 1.  Adhesion G protein-coupled receptors: structure, signaling, physiology, and pathophysiology.

Authors:  Trisha Lala; Randy A Hall
Journal:  Physiol Rev       Date:  2022-04-25       Impact factor: 46.500

2.  β-Cryptoxanthin Improves p62 Accumulation and Muscle Atrophy in the Soleus Muscle of Senescence-Accelerated Mouse-Prone 1 Mice.

Authors:  Mari Noguchi; Tomoya Kitakaze; Yasuyuki Kobayashi; Katsuyuki Mukai; Naoki Harada; Ryoichi Yamaji
Journal:  Nutrients       Date:  2020-07-22       Impact factor: 5.717

3.  Specific and direct modulation of the interaction between adhesion GPCR GPR56/ADGRG1 and tissue transglutaminase 2 using synthetic ligands.

Authors:  Gabriel S Salzman; Shu Zhang; Celia G Fernandez; Demet Araç; Shohei Koide
Journal:  Sci Rep       Date:  2020-10-09       Impact factor: 4.379

Review 4.  The role of GPR56/ADGRG1 in health and disease.

Authors:  Abhishek Kumar Singh; Hsi-Hsien Lin
Journal:  Biomed J       Date:  2021-05-04       Impact factor: 4.910

5.  Impaired Skeletal Muscle Development and Regeneration in Transglutaminase 2 Knockout Mice.

Authors:  Zsófia Budai; Nour Al-Zaeed; Péter Szentesi; Hajnalka Halász; László Csernoch; Zsuzsa Szondy; Zsolt Sarang
Journal:  Cells       Date:  2021-11-09       Impact factor: 6.600

Review 6.  Role of ADGRG1/GPR56 in Tumor Progression.

Authors:  Kwai-Fong Ng; Tse-Ching Chen; Martin Stacey; Hsi-Hsien Lin
Journal:  Cells       Date:  2021-11-29       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.